These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18569468)

  • 1. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology.
    Badawy AM; Khiary M; Sherif LS; Hassan M; Ragab A; Abdelall I
    J Obstet Gynaecol; 2008 Apr; 28(3):280-4. PubMed ID: 18569468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology.
    Tzafettas J; Petropoulos P; Psarra A; Delkos D; Papaloukas C; Giannoulis H; Kalogiros G; Gkoutzioulis F
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):22-6. PubMed ID: 15866081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology.
    Tzafettas J; Mamopoulos A; Anapliotis A; Loufopoulos A; Psarra A; Klearchou N; Mamopoulos M
    Clin Exp Obstet Gynecol; 2002; 29(4):267-70. PubMed ID: 12635742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
    de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
    Trials; 2015 May; 16():208. PubMed ID: 25947329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial.
    Shaaban OM; Abbas AM; Zahran KM; Fathalla MM; Anan MA; Salman SA
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):567-572. PubMed ID: 27572887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.
    Pasquier E; de Saint Martin L; Bohec C; Chauleur C; Bretelle F; Marhic G; Le Gal G; Debarge V; Lecomte F; Denoual-Ziad C; Lejeune-Saada V; Douvier S; Heisert M; Mottier D
    Blood; 2015 Apr; 125(14):2200-5. PubMed ID: 25636341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
    McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
    Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
    Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Ramadan DI; Fouda IM
    J Obstet Gynaecol; 2010; 30(8):842-6. PubMed ID: 21126127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials.
    Wang G; Zhang R; Li C; Chen A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7601-7608. PubMed ID: 34311655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.